Butterfly Network (BFLY) Cash & Equivalents (2019 - 2026)
Butterfly Network's (BFLY) quarterly Cash & Equivalents came in at $138.0 million in Q1 2026, down 11.12% year-on-year from $155.2 million in Q1 2025, and down 8.33% quarter-over-quarter from $150.5 million in Q4 2025.
Butterfly Network (BFLY) Cash & Equivalents (2019 - 2026) Analysis & Trends
Butterfly Network has disclosed Cash & Equivalents across 8 years of filings, most recently posting $138.0 million for Q1 2026.
- Cash & Equivalents for Q1 2026 came in at $138.0 million, down 11.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $138.0 million (down 11.12% YoY), and the FY2025 annual result was $150.5 million, up 69.52% from the prior year.
- Cash & Equivalents came in at $138.0 million for Q1 2026 at Butterfly Network, down from $150.5 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $359.9 million in Q1 2022 to a low of $88.8 million in Q4 2024.
- The 5-year median for Cash & Equivalents is $150.0 million (2023), against an average of $165.0 million.
- Peak annual rise in Cash & Equivalents reached 1809.29% in 2022, while the deepest fall reached 61.56% in 2022.
- Butterfly Network's Cash & Equivalents stood at $162.6 million in 2022, then declined by 17.3% to $134.4 million in 2023, then plunged by 33.97% to $88.8 million in 2024, then surged by 69.52% to $150.5 million in 2025, then fell by 8.33% to $138.0 million in 2026.
- The last three Cash & Equivalents figures came in at $138.0 million (Q1 2026), $150.5 million (Q4 2025), and $144.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 2.45 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 2.29 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.03 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 1.12 Bn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 439.60 Mn |
| 10 | Butterfly Network | 1.42 Bn | 1.28 Bn | 18.29 Mn | 137.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 137.95 Mn |
| Dec 31, 2025 | 150.49 Mn |
| Sep 30, 2025 | 144.23 Mn |
| Jun 30, 2025 | 148.14 Mn |
| Mar 31, 2025 | 155.21 Mn |
| Dec 31, 2024 | 88.78 Mn |
| Sep 30, 2024 | 93.76 Mn |
| Jun 30, 2024 | 102.05 Mn |
| Mar 31, 2024 | 112.65 Mn |
| Dec 31, 2023 | 134.44 Mn |
| Sep 30, 2023 | 150.01 Mn |
| Jun 30, 2023 | 166.81 Mn |
| Mar 31, 2023 | 193.81 Mn |
| Dec 31, 2022 | 162.56 Mn |
| Sep 30, 2022 | 193.31 Mn |
| Jun 30, 2022 | 310.80 Mn |
| Mar 31, 2022 | 359.90 Mn |
| Dec 31, 2021 | 422.84 Mn |
| Sep 30, 2021 | 153.33 Mn |
| Jun 30, 2021 | 19.61 Mn |